Nov 3 (Reuters) - Cipher Pharmaceuticals Inc
* Cipher Pharmaceuticals reports Q3 2017 operating & financial results
* Cipher Pharmaceuticals Inc - qtrly total net revenue increased 29% to $10.1 million, from $7.8 million in Q3 2016
* Cipher Pharma - on Nov 2, Galephar confirmed resumption of production at both Juncos, Humacao manufacturing facilities
* Cipher Pharma - does not anticipate any impact to product supply resulting from interruption of manufacturing at Galephar’s facilities in Puerto Rico
* Cipher Pharmaceuticals Inc - qtrly income from continuing operations of $3.9 million, or $0.15 per basic share
* Q3 revenue view $9.2 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.